FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Veterinary world2021; 14(4); 835-840; doi: 10.14202/vetworld.2021.835-840

Orally administered β-glucan improves the hemolytic activity of the complement system in horses.

Abstract: Immune-modulating molecules mainly act on innate immune cells, which are central to early defense against invading pathogens and contribute to developing adaptive immunity. Yeast-extracted β-glucan, a model immune-modulating molecule, is widely used in several animal species; however, its effect on horse immune parameters has not been thoroughly investigated yet. This study aimed to evaluate the effects of orally administered β-glucan on selected innate immune parameters in horses. Methods: Eighteen thoroughbred horses were assigned equally into three groups as follows: One control group (no β-glucan) and two β-glucan experimental groups (one received 125 mg and the other 2 g of β-glucan per day for 28 days). Blood samples were collected before and at the end of the experiment for hematological analysis, whole blood phagocytosis, respiratory burst assays, and to assess the serum lysozyme and complement hemolytic activities. Results: At the end of the experiment, significant decreases (p<0.05) in monocyte numbers were observed in the control horses (258.8±45.9 vs. 115.3±41.5) and in those fed 125 mg/day of β-glucan (208.8±72.3 vs. 99.2±60.7), whereas a significant increase in numbers was noted in the horses that were fed 2 g/day of β-glucan (303.5±45.8 vs. 429.8±86.0; p<0.05). The natural hemolytic activity of the complement was higher only in horses fed 2 g/day of β-glucan (p=0.018) compared to the other groups. The hemolytic activity in the classical pathway was higher in those fed 125 mg/day (p=0.0035) and 2 g/day of β-glucan (p=0.0001). Conclusions: β-glucan improves important innate immune parameters and might be fed to horses before stressful events.
Copyright: © Picetti, et al.
Get Full Text
Publication Date: 2021-04-05 PubMed ID: 34083928PubMed Central: PMC8167517DOI: 10.14202/vetworld.2021.835-840Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study evaluates the impact of orally taken β-glucan, a yeast-extracted immune-modulating molecule, on the innate immune parameters of horses, finding that it enhances key innate immune metrics and might be beneficial when given to horses before stressful situations.

Study Objective and Methods

  • The study explored the effects of β-glucan, a nutrient derived from yeast known to modulate immunity, on the immune system of horses, a species for which this compound hasn’t been thoroughly tested.
  • A total of 18 thoroughbred horses were categorized into three groups: one group that didn’t receive β-glucan (control group), one that received 125 mg of β-glucan every day for a month and one that received 2 g of β-glucan each day for a month.
  • Using blood samples collected at the beginning and end of the experiment, researchers performed hematological analysis, phagocytosis on blood collected, respiratory burst assays, and assessment of complement hemolytic activities and the presence of serum lysozyme.

Study Results

  • At the conclusion of the study, the control group and group given 125 mg/day of β-glucan noticed a significant drop in monocyte numbers. Conversely, the group fed 2 g/day of β-glucan experienced a substantial surge in these cells.
  • The study also revealed elevated natural hemolytic activity of the complement system, specifically in the horses that ingested 2 g/day of β-glucan when compared with other groups. This activity is a protective immune response which results in the lysing (bursting) of foreign cells in the bloodstream.
  • Additionally, the complement’s classical pathway hemolytic activity also spiked in the group fed 125 mg/day and the group that ingested 2 g/day of β-glucan. This pathway is a part of the immune response that helps antibodies destroy pathogens.

Conclusions

  • In conclusion, β-glucan appears to strengthen key aspects of the innate immune response in horses, as observed through various immune parameters within the blood.
  • This could hint at its use as a feed supplementary for horses ahead of stressful situations where their immune system may be weakened or challenged.

Cite This Article

APA
Picetti TS, Soveral LF, Miotto R, Erpen LMS, Kreutz Y, Guizzo JA, Frandoloso R, Kreutz LC. (2021). Orally administered β-glucan improves the hemolytic activity of the complement system in horses. Vet World, 14(4), 835-840. https://doi.org/10.14202/vetworld.2021.835-840

Publication

Veterinary world
ISSN: 0972-8988
NlmUniqueID: 101504872
Country: India
Language: English
Volume: 14
Issue: 4
Pages: 835-840

Researcher Affiliations

Picetti, Taline Scalco
  • Laboratório de Microbiologia e Imunologia Avançada, Faculdade de Agronomia e Medicina Veterinária, Universidade de Passo Fundo, 99052-900 Passo Fundo, RS, Brazil.
Soveral, Lucas de Figueiredo
  • Laboratório de Microbiologia e Imunologia Avançada, Faculdade de Agronomia e Medicina Veterinária, Universidade de Passo Fundo, 99052-900 Passo Fundo, RS, Brazil.
Miotto, Rovian
  • Laboratório de Microbiologia e Imunologia Avançada, Faculdade de Agronomia e Medicina Veterinária, Universidade de Passo Fundo, 99052-900 Passo Fundo, RS, Brazil.
Erpen, Luana Marina Scheer
  • Laboratório de Microbiologia e Imunologia Avançada, Faculdade de Agronomia e Medicina Veterinária, Universidade de Passo Fundo, 99052-900 Passo Fundo, RS, Brazil.
Kreutz, Yasmin
  • Laboratório de Microbiologia e Imunologia Avançada, Faculdade de Agronomia e Medicina Veterinária, Universidade de Passo Fundo, 99052-900 Passo Fundo, RS, Brazil.
Guizzo, João Antônio
  • Programa de Pós-Graduação em Medicina Veterinária Preventiva, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil.
Frandoloso, Rafael
  • Laboratório de Microbiologia e Imunologia Avançada, Faculdade de Agronomia e Medicina Veterinária, Universidade de Passo Fundo, 99052-900 Passo Fundo, RS, Brazil.
Kreutz, Luiz Carlos
  • Laboratório de Microbiologia e Imunologia Avançada, Faculdade de Agronomia e Medicina Veterinária, Universidade de Passo Fundo, 99052-900 Passo Fundo, RS, Brazil.

References

This article includes 28 references
  1. Frellstedt L, Gosset P, Kervoaze G, Hans A, Desmet C, Pirottin D, Bureau F, Lekeux P, Art T. The innate immune response of equine bronchial epithelial cells is altered by training.. Vet Res 2015 Jan 17;46(1):3.
    pmc: PMC4297379pubmed: 25595212doi: 10.1186/s13567-014-0126-3google scholar: lookup
  2. Frellstedt L, Waldschmidt I, Gosset P, Desmet C, Pirottin D, Bureau F, Farnir F, Franck T, Dupuis-Tricaud MC, Lekeux P, Art T. Training modifies innate immune responses in blood monocytes and in pulmonary alveolar macrophages.. Am J Respir Cell Mol Biol 2014 Jul;51(1):135-42.
    pubmed: 24502337doi: 10.1165/rcmb.2013-0341ocgoogle scholar: lookup
  3. Horohov DW, Breathnach CC, Sturgill TL, Rashid C, Stiltner JL, Strong D, Nieman N, Holland RE. In vitro and in vivo modulation of the equine immune response by parapoxvirus ovis.. Equine Vet J 2008 Jul;40(5):468-72.
    pubmed: 18678554doi: 10.2746/042516408x322111google scholar: lookup
  4. Woodward EM, Christoffersen M, Horohov D, Squires EL, Troedsson MH. The effect of treatment with immune modulators on endometrial cytokine expression in mares susceptible to persistent breeding-induced endometritis.. Equine Vet J 2015 Mar;47(2):235-9.
    pubmed: 24645833doi: 10.1111/evj.12266google scholar: lookup
  5. Paillot R. A systematic review of the immune-modulators Parapoxvirus ovis and Propionibacterium acnes for the prevention of respiratory disease and other infections in the horse.. Vet Immunol Immunopathol 2013 May 15;153(1-2):1-9.
    pubmed: 23481655doi: 10.1016/j.vetimm.2013.01.010google scholar: lookup
  6. Davis E. The Use of Vaccines and Immunostimulants in the Horse. In:NAVC Conference 2013 Large Animals. 2013. pp. 1–12.
  7. Bergmann-Leitner ES, Leitner WW. Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators.. Vaccines (Basel) 2014 Apr 10;2(2):252-96.
    pmc: PMC4494256pubmed: 26344620doi: 10.3390/vaccines2020252google scholar: lookup
  8. Friebe A, Siegling A, Friederichs S, Volk HD, Weber O. Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells.. J Virol 2004 Sep;78(17):9400-11.
    pmc: PMC506965pubmed: 15308734doi: 10.1128/jvi.78.17.9400-9411.2004google scholar: lookup
  9. Ryan C, Giguère S, Fultz L, Long MT, Crawford PC. Effects of two commercially available immunostimulants on leukocyte function of foals following ex vivo exposure to Rhodococcus equi.. Vet Immunol Immunopathol 2010 Dec 1;138(3):198-205.
    pubmed: 20822815doi: 10.1016/j.vetimm.2010.07.027google scholar: lookup
  10. Hue ES, Richard EA, Fortier CI, Fortier GD, Paillot R, Raue R, Pronost SL. Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment.. Vaccines (Basel) 2017 Sep 19;5(3).
    pmc: PMC5620559pubmed: 28925977doi: 10.3390/vaccines5030028google scholar: lookup
  11. Adams AA, Horohov DW. The effect of an immunomodulator (parapoxvirus ovis) on cell-mediated immunity (CMI) in abruptly weaned foals.. Vet Immunol Immunopathol 2013 May 15;153(1-2):118-22.
    pubmed: 23312290doi: 10.1016/j.vetimm.2012.11.020google scholar: lookup
  12. Stier H, Ebbeskotte V, Gruenwald J. Immune-modulatory effects of dietary Yeast Beta-1,3/1,6-D-glucan.. Nutr J 2014 Apr 28;13:38.
    pmc: PMC4012169pubmed: 24774968doi: 10.1186/1475-2891-13-38google scholar: lookup
  13. Soltanian S, Stuyven E, Cox E, Sorgeloos P, Bossier P. Beta-glucans as immunostimulant in vertebrates and invertebrates.. Crit Rev Microbiol 2009;35(2):109-38.
    pubmed: 19514911doi: 10.1080/10408410902753746google scholar: lookup
  14. Camilli G, Tabouret G, Quintin J. The Complexity of Fungal β-Glucan in Health and Disease: Effects on the Mononuclear Phagocyte System.. Front Immunol 2018;9:673.
    pmc: PMC5932370pubmed: 29755450doi: 10.3389/fimmu.2018.00673google scholar: lookup
  15. Cywinska A, Szarska E, Degorski A, Guzera M, Gorecka R, Strzelec K, Kowalik S, Schollenberger A, Winnicka A. Blood phagocyte activity after race training sessions in Thoroughbred and Arabian horses.. Res Vet Sci 2013 Oct;95(2):459-64.
    pubmed: 23664016doi: 10.1016/j.rvsc.2013.04.020google scholar: lookup
  16. Sutili FJ, Kreutz LC, Flores FC, da Silva CB, Kirsten KS, Ana P, Voloski S, Frandoloso R, Pinheiro CG, Heinzmann BM, Baldisserotto B. Effect of dietary supplementation with citral-loaded nanostructured systems on innate immune responses and gut microbiota of silver catfish (Rhamdia quelen). J. Funct. Foods 2019;60:103454.
  17. Zelek WM, Harris CL, Morgan BP. Extracting the barbs from complement assays: Identification and optimisation of a safe substitute for traditional buffers.. Immunobiology 2018 Dec;223(12):744-749.
    pubmed: 30033110doi: 10.1016/j.imbio.2018.07.016google scholar: lookup
  18. Dalmo RA, Bøgwald J. Beta-glucans as conductors of immune symphonies.. Fish Shellfish Immunol 2008 Oct;25(4):384-96.
    pubmed: 18606550doi: 10.1016/j.fsi.2008.04.008google scholar: lookup
  19. Leentjens J, Quintin J, Gerretsen J, Kox M, Pickkers P, Netea MG. The effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study.. PLoS One 2014;9(9):e108794.
    pmc: PMC4182605pubmed: 25268806doi: 10.1371/journal.pone.0108794google scholar: lookup
  20. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models.. J Immunol 2004 Jul 15;173(2):797-806.
    pubmed: 15240666doi: 10.4049/jimmunol.173.2.797google scholar: lookup
  21. Pionnier N, Falco A, Miest J, Frost P, Irnazarow I, Shrive A, Hoole D. Dietary β-glucan stimulate complement and C-reactive protein acute phase responses in common carp (Cyprinus carpio) during an Aeromonas salmonicida infection.. Fish Shellfish Immunol 2013 Mar;34(3):819-31.
    pubmed: 23291104doi: 10.1016/j.fsi.2012.12.017google scholar: lookup
  22. Stuyven E, Cox E, Vancaeneghem S, Arnouts S, Deprez P, Goddeeris BM. Effect of beta-glucans on an ETEC infection in piglets.. Vet Immunol Immunopathol 2009 Mar 15;128(1-3):60-6.
    pubmed: 19046775doi: 10.1016/j.vetimm.2008.10.311google scholar: lookup
  23. Kapellos TS, Bonaguro L, Gemünd I, Reusch N, Saglam A, Hinkley ER, Schultze JL. Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases.. Front Immunol 2019;10:2035.
    pmc: PMC6728754pubmed: 31543877doi: 10.3389/fimmu.2019.02035google scholar: lookup
  24. Kantari C, Pederzoli-Ribeil M, Witko-Sarsat V. The role of neutrophils and monocytes in innate immunity.. Contrib Microbiol 2008;15:118-146.
    pubmed: 18511859doi: 10.1159/000136335google scholar: lookup
  25. Heesterbeek DAC, Angelier ML, Harrison RA, Rooijakkers SHM. Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications.. J Innate Immun 2018;10(5-6):455-464.
    pmc: PMC6784045pubmed: 30149378doi: 10.1159/000491439google scholar: lookup
  26. Hawlisch H, Köhl J. Complement and Toll-like receptors: key regulators of adaptive immune responses.. Mol Immunol 2006 Jan;43(1-2):13-21.
    pubmed: 16019071doi: 10.1016/j.molimm.2005.06.028google scholar: lookup
  27. Leid RW, Coley SC, Blanchard DP, Perryman LE. Equine alternative pathway activation by unsensitized rabbit red blood cells.. Vet Immunol Immunopathol 1985 May;9(1):71-85.
    pubmed: 4024451doi: 10.1016/0165-2427(85)90131-xgoogle scholar: lookup
  28. Yarnall DP, Boyle MD. Restriction in the lytic efficiency of complement of different erythrocyte targets: a re-examination of the activities of horse C8 and C9.. Mol Immunol 1986 Aug;23(8):823-9.
    pubmed: 3796626doi: 10.1016/0161-5890(86)90067-2google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,928 horse owners like you who receive our email updates on horse health and nutrition.